Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs).

Trial Profile

Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs).

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2011

At a glance

  • Drugs Piperacillin/tazobactam (Primary)
  • Indications Escherichia coli infections; Klebsiella infections
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 21 Jun 2010 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
    • 21 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top